Gastrointestinal microbiota-mediated control of enteric pathogens

Annual Review of Genetics

Volumn 48, Issue , 2014, Pages 361-382

  Yurist Doutsch, Sophie ^a   Arrieta, Marie Claire ^a   Vogt, Stefanie L ^a   Finlay, B Brett ^a,b  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Clostridium difficile; colonization resistance; Escherichia coli; intestinal microbiota; Salmonella enterica

Indexed keywords

ADAPTIVE IMMUNITY; ARTICLE; ATOPY; BACTERIAL COLONIZATION; CITROBACTER RODENTIUM; CLOSTRIDIUM DIFFICILE; COLITIS; ENTEROPATHOGENIC ESCHERICHIA COLI; HUMAN; IMMUNE SYSTEM; INFLAMMATORY BOWEL DISEASE; INNATE IMMUNITY; INTESTINE FLORA; INTESTINE INFECTION; INTESTINE LYMPHATIC TISSUE; MAMMAL; MICROFLORA; NONHUMAN; OBESITY; SALMONELLA ENTERICA; ANIMAL; ESCHERICHIA COLI; GASTROINTESTINAL TRACT; GENETICS; IMMUNOLOGY; MICROBIOLOGY; PATHOGENICITY; PEPTOCLOSTRIDIUM DIFFICILE;

CLOSTRIDIUM DIFFICILE; ESCHERICHIA COLI; SALMONELLA ENTERICA;

ANIMALS; CLOSTRIDIUM DIFFICILE; COLITIS; ESCHERICHIA COLI; GASTROINTESTINAL TRACT; HUMANS; MICROBIOTA; SALMONELLA ENTERICA;

EID: 84913591484     PISSN: 00664197     EISSN: 15452948     Source Type: Book Series    
DOI: 10.1146/annurev-genet-120213-092421     Document Type: Article

References (129)

1. Abrams GD, Bauer H, Sprinz H. 1963. Influence of the normal flora onmucosal morphology and cellular renewal in the ileum. A comparison of germ-free and conventional mice. Lab. Invest. 12:355-64
2. Arrieta Mendez M-C. 2011. The role of small intestinal permeability in the pathogenesis of colitis in the interleukin-10 gene deficient mouse. PhD Diss. Univ. Alberta, Edmonton AB, Can.
3. Atarashi K, Nishimura J, Shima T, Umesaki Y, Yamamoto M, et al. 2008. ATP drives lamina propria T(H)17 cell differentiation. Nature 455:808-12
4. Atarashi K, Tanoue T, Shima T, Imaoka A, Kuwahara T, et al. 2011. Induction of colonic regulatory T cells by indigenous Clostridium species. Science 331:337-41
5. Ather JL, Ckless K, Martin R, Foley KL, Suratt BT, et al. 2011. Serum amyloid A activates the NLRP3 inflammasome and promotes Th17 allergic asthma in mice. J. Immunol. 187:64-73
6. Barthel M, Hapfelmeier S, Quintanilla-Martinez L, Kremer M, Rohde M, et al. 2003. Pretreatment of mice with streptomycin provides a Salmonella enterica serovar Typhimurium colitis model that allows analysis of both pathogen and host. Infect. Immun. 71:2839-58
7. Beaugerie L, Flahault A, Barbut F, Atlan P, Lalande V, et al. 2003. Antibiotic-Associated diarrhoea and Clostridium difficile in the community. Aliment. Pharmacol. Thera. 17:905-12
8. Bergstrom KSB, Kissoon-Singh V, Gibson DL, Ma C, Montero M, et al. 2010. Muc2 protects against lethal infectious colitis by disassociating pathogenic and commensal bacteria from the colonic mucosa. PLOS Pathog. 6:e1000902
9. Best EL, Freeman J, Wilcox MH. 2012. Models for the study of Clostridium difficile infection. GutMicrobes 3:145-67
10. Bisgaard H, Li N, Bonnelykke K, Chawes BL, Skov T, et al. 2011. Reduced diversity of the intestinal microbiota during infancy is associated with increased risk of allergic disease at school age. J. Allergy Clinic. Immunol. 128:646-52e1-5
11. Bouskra D, Brezillon C, Berard M, Werts C, Varona R, et al. 2008. Lymphoid tissue genesis induced by commensals through NOD1 regulates intestinal homeostasis. Nature 456:507-10
12. Buffie CG, Jarchum I, Equinda M, Lipuma L, Gobourne A, et al. 2012. Profound alterations of intestinal microbiota following a single dose of clindamycin results in sustained susceptibility to Clostridium difficile-induced colitis. Infect. Immun. 80:62-73
13. Buonocore S, Ahern PP, Uhlig HH, Ivanov II, Littman DR, et al. 2010. Innate lymphoid cells drive interleukin-23-dependent innate intestinal pathology. Nature 464:1371-75
14. Carey CM, Kostrzynska M, Ojha S, Thompson S. 2008. The effect of probiotics and organic acids on Shiga-toxin 2 gene expression in enterohemorrhagic Escherichia coli O157:H7. J. Microbiol. Methods 73:125-32
15. Chang JY, Antonopoulos DA, Kalra A, Tonelli A, Khalife WT, et al. 2008. Decreased diversity of the fecal microbiome in recurrent Clostridium difficile-Associated diarrhea. J. Infect. Dis. 197:435-38
16. Chen Z, Cobbold SP, Waldmann H, Metcalfe SM. 1994. Tolerance induction in concordant heartxenografted mice by CD4 and CD8 monoclonal antibodies. Transplant. Proc. 26:1199-200
17. Cherrington CA, Hinton M, Pearson GR, Chopra I. 1991. Short-chain organic acids at ph 5. 0 kill Escherichia coli and Salmonella spp. without causing membrane perturbation. J. Appl. Bacteriol. 70:161-65
18. Costello EK, Lauber CL, Hamady M, Fierer N, Gordon JI, Knight R. 2009. Bacterial community variation in human body habitats across space and time. Science 326:1694-97
19. Croswell A, Amir E, Teggatz P, Barman M, Salzman NH. 2009. Prolonged impact of antibiotics on intestinal microbial ecology and susceptibility to enteric Salmonella infection. Infect. Immun. 77:2741-53
20. Croxen MA, Finlay BB. 2010. Molecular mechanisms of Escherichia coli pathogenicity. Nat. Rev. Microbiol. 8:26-38
21. Croxen MA, Law RJ, Scholz R, Keeney KM, Wlodarska M, Finlay BB. 2013. Recent advances in understanding enteric pathogenic Escherichia coli. Clin. Microbiol. Rev. 26:822-80
22. de Jong HK, Parry CM, van der Poll T, Wiersinga WJ. 2012. Host-pathogen interaction in invasive salmonellosis. PLOS Pathog. 8:e1002933
23. de Sablet T, Chassard C, Bernalier-Donadille A, Vareille M, Gobert AP, Martin C. 2009. Human microbiota-secreted factors inhibit Shiga toxin synthesis by enterohemorrhagic Escherichia coli O157:H7. Infect. Immun. 77:783-90
24. Delves PJ, Roitt IM. 2000. The immune system. First of two parts. New Engl. J. Med. 343:37-49
25. Deriu E, Liu JZ, Pezeshki M, Edwards RA, Ochoa RJ, et al. 2013. Probiotic bacteria reduce Salmonella typhimurium intestinal colonization by competing for iron. Cell Host Microbe 14:26-37
26. Dobber R, Hertogh-Huijbregts A, Rozing J, Bottomly K, Nagelkerken L. 1992. The involvement of the intestinal microflora in the expansion of CD4+ T cells with a naive phenotype in the periphery. Dev. Immunol. 2:141-50
27. Eckburg PB, Bik EM, Bernstein CN, Purdom E, Dethlefsen L, et al. 2005. Diversity of the human intestinal microbial flora. Science 308:1635-38
28. Endt K, Stecher B, Chaffron S, Slack E, Tchitchek N, et al. 2010. The microbiota mediates pathogen clearance from the gut lumen after non-typhoidal Salmonella diarrhea. PLOS Pathog. 6:e1001097
29. Ferreira RB, Gill N, Willing BP, Antunes LC, Russell SL, et al. 2011. The intestinal microbiota plays a role in Salmonella-induced colitis independent of pathogen colonization. PLOS ONE 6:e20338
30. Frank DN, St. Amand AL, Feldman RA, Boedeker EC, Harpaz N, Pace NR. 2007. Molecularphylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proc. Natl. Acad. Sci. USA 104:13780-85
31. Gaboriau-Routhiau V, Rakotobe S, Lecuyer E, Mulder I, Lan A, et al. 2009. The key role of segmented filamentous bacteria in the coordinated maturation of gut helper T cell responses. Immunity 31:677-89
32. Garner CD, Antonopoulos DA, Wagner B, Duhamel GE, Keresztes I, et al. 2009. Perturbation of the small intestine microbial ecology by streptomycin alters pathology in a Salmonella enterica serovar typhimurium murine model of infection. Infect. Immun. 77:2691-702
33. Ghosh S, Dai C, Brown K, Rajendiran E, Makarenko S, et al. 2011. Colonic microbiota alters host susceptibility to infectious colitis by modulating inflammation, redox status, and ion transporter gene expression. Am. J. Physiol. Gastrointest. Liver Physiol. 301:G39-49
34. Gill N, Ferreira RB, Antunes LC, Willing BP, Sekirov I, et al. 2012. Neutrophil elastase alters the murine gut microbiota resulting in enhanced Salmonella colonization. PLOS ONE 7:e49646
35. Gu S, Chen D, Zhang JN, Lv X, Wang K, et al. 2013. Bacterial community mapping of the mouse gastrointestinal tract. PLOS ONE 8:e74957
36. Gustafsson JK, Navabi N, Rodriguez-Pineiro AM, Alomran AHA, Premaratne P, et al. 2013. Dynamic changes in mucus thickness and ion secretion during Citrobacter rodentium infection and clearance. PLOS ONE 8:e84430
37. Herold S, Paton JC, Srimanote P, Paton AW. 2009. Differential effects of short-chain fatty acids and iron on expression of iha in Shiga-toxigenic Escherichia coli. Microbiology 155:3554-63
38. Hum. Microbiome Proj. C. 2012. Structure, function and diversity of the healthy human microbiome. Nature 486:207-14
39. Hung CC, Garner CD, Slauch JM, Dwyer ZW, Lawhon SD, et al. 2013. The intestinal fatty acid propionate inhibits Salmonella invasion through the post-translational control of Hil D. Mol. Microbiol. 87:1045-60
40. Hurley BP, McCormick BA. 2004. Intestinal epithelial defense systems protect against bacterial threats. Curr. Gastroenterol. Rep. 6:355-61
41. Iizuka M, Konno S, Itou H, Chihara J, Toyoshima I, et al. 2004. Novel evidence suggesting Clostridium difficile is present in human gut microbiotamore frequently than previously suspected. Microbiol. Immunol. 48:889-92
42. Ivanov II, Atarashi K, Manel N, Brodie EL, Shima T, et al. 2009. Induction of intestinal Th17 cells by segmented filamentous bacteria. Cell 139:485-98
43. Ivanov II, Frutos Rde L, Manel N, Yoshinaga K, Rifkin DB, et al. 2008. Specific microbiota direct the differentiation of IL-17-producing T-helper cells in the mucosa of the small intestine. Cell Host Microbe 4:337-49
44. Jank T, Aktories K. 2008. Structure and mode of action of clostridial glucosylating toxins: the ABCD model. Trends Microbiol. 16:222-29
45. Johansson MEV, Phillipson M, Petersson J, Velcich A, Holm L, Hansson GC. 2008. The inner of the two Muc2 mucin-dependent mucus layers in colon is devoid of bacteria. Proc. Natl. Acad. Sci. USA 105:15064-69
46. Jones BD, Ghori N, Falkow S. 1994. Salmonella typhimurium initiates murine infection by penetrating and destroying the specialized epithelial M cells of the Peyer's patches. J. Exp. Med. 180:15-23
47. Jones SA, Jorgensen M, Chowdhury FZ, Rodgers R, Hartline J, et al. 2008. Glycogen and maltose utilization by Escherichia coli O157:H7 in the mouse intestine. Infect. Immun. 76:2531-40
48. Just I, Richter HP, Prepens U, von Eichel-Streiber C, Aktories K. 1994. Probing the action of Clostridium difficile toxin B in Xenopus laevis oocytes. J. Cell Sci. 107(Pt. 6):1653-59
49. Just I, Selzer J, Wilm M, von Eichel-Streiber C, Mann M, Aktories K. 1995. Glucosylation of Rho proteins by Clostridium difficile toxin B. Nature 375:500-3
50. Kagnoff MF. 1993. Immunology of the intestinal tract. Gastroenterology 105:1275-80
51. Kalliomaki M, Kirjavainen P, Eerola E, Kero P, Salminen S, Isolauri E. 2001. Distinct patterns of neonatal gut microflora in infants in whom atopy was and was not developing. J. Allergy Clin. Immunol. 107:129-34
52. Kamada N, Kim Y-G, Sham HP, Vallance BA, Puente JL, et al. 2012. Regulated virulence controls the ability of a pathogen to compete with the gut microbiota. Science 336:1325-29
53. Kaper JB, Nataro JP, Mobley HL. 2004. Pathogenic Escherichia coli. Nat. Rev. Microbiol. 2:123-40
54. Kassinen A, Krogius-Kurikka L, Makivuokko H, Rinttila T, Paulin L, et al. 2007. The fecal microbiota of irritable bowel syndrome patients differs significantly from that of healthy subjects. Gastroenterology 133:24-33
55. Kelly CP, Pothoulakis C, LaMont JT. 1994. Clostridium difficile colitis. New Engl. J. Med. 330:257-62
56. Kinnebrew MA, Ubeda C, Zenewicz LA, Smith N, Flavell RA, Pamer EG. 2010. Bacterial flagellin stimulates toll-like receptor 5-dependent defense against vancomycin-resistant enterococcus infection. J. Infect. Dis. 201:534-43
57. Kurokawa K, Itoh T, Kuwahara T, Oshima K, Toh H, et al. 2007. Comparative metagenomics revealed commonly enriched gene sets in human gut microbiomes. DNA Res. 14:169-81
58. Langkamp-Henken B, Glezer JA, Kudsk KA. 1992. Immunologic structure and function of the gastrointestinal tract. Nutr. Clin. Pract. 7:100-8
59. Larson HE, Barclay FE, Honour P, Hill ID. 1982. Epidemiology of Clostridium difficile in infants. J. Infect. Dis. 146:727-33
60. Lathrop SK, Bloom SM, Rao SM, Nutsch K, Lio CW, et al. 2011. Peripheral education of the immune system by colonic commensal microbiota. Nature 478:250-54
61. Lawhon SD, Maurer R, Suyemoto M, Altier C. 2002. Intestinal short-chain fatty acids alter Salmonella typhimurium invasion gene expression and virulence through BarA/Sir A. Mol. Microbiol. 46:1451-64
62. Lawley TD, Bouley DM, Hoy YE, Gerke C, Relman DA, Monack DM. 2008. Host transmission of Salmonella enterica serovar Typhimurium is controlled by virulence factors and indigenous intestinal microbiota. Infect. Immun. 76:403-16
63. Leatham MP, Banerjee S, Autieri SM, Mercado-Lubo R, Conway T, Cohen PS. 2009. Precolonized human commensal Escherichia coli strains serve as a barrier to E. Coli O157:H7 growth in the streptomycintreated mouse intestine. Infect. Immun. 77:2876-86
64. Lee YK, Menezes JS, Umesaki Y, Mazmanian SK. 2010. Microbes and Health SacklerColloquium: proinflammatory T-cell responses to gut microbiota promote experimental autoimmune encephalomyelitis. Proc. Natl. Acad. Sci. USA 108(Suppl. 1):4615-22
65. Ley RE, Turnbaugh PJ, Klein S, Gordon JI. 2006. Microbial ecology: human gut microbes associated with obesity. Nature 444:1022-23
66. Louie TJ, Cannon K, Byrne B, Emery J, Ward L, et al. 2012. Fidaxomicin preserves the intestinal microbiome during and after treatment of Clostridium difficile infection (CDI) and reduces both toxin reexpression and recurrence of CDI. Clin. Infect. Dis. 55(Suppl. 2):S132-42
67. Luckey TD. 1972. Introduction to intestinal microecology. Am. J. Clin. Nutr. 25:1292-94
68. Macdonald JC, Torriani FJ, Morse LS, Karavellas MP, Reed JB, Freeman WR. 1998. Lack of reactivation of cytomegalovirus (CMV) retinitis after stopping CMV maintenance therapy in AIDS patients with sustained elevations in CD4 T cells in response to highly active antiretroviral therapy. J. Infect. Dis. 177:1182-87
69. Maier L, Vyas R, Cordova CD, Lindsay H, Schmidt TS, et al. 2013. Microbiota-derived hydrogen fuels Salmonella typhimurium invasion of the gut ecosystem. Cell Host Microbe 14:641-51
70. Malinen E, Rinttila T, Kajander K, Matto J, Kassinen A, et al. 2005. Analysis of the fecal microbiota of irritable bowel syndrome patients and healthy controls with real-time PCR. Am. J. Gastroenterol. 100:373-82
71. Mattila E, Uusitalo-Seppala R, Wuorela M, Lehtola L, Nurmi H, et al. 2012. Fecal transplantation, through colonoscopy, is effective therapy for recurrent Clostridium difficile infection. Gastroenterology 142:490-96
72. Mazmanian SK, Liu CH, Tzianabos AO, Kasper DL. 2005. An immunomodulatory molecule of symbiotic bacteria directs maturation of the host immune system. Cell 122:107-18
73. Mazmanian SK, Round JL, Kasper DL. 2008. A microbial symbiosis factor prevents intestinal inflammatory disease. Nature 453:620-25
74. McFarland LV, Mulligan ME, Kwok RY, Stamm WE. 1989. Nosocomial acquisition of Clostridium difficile infection. New Engl. J. Med. 320:204-10
75. Miranda RL, Conway T, Leatham MP, Chang DE, Norris WE, et al. 2004. Glycolytic and gluconeogenic growth of Escherichia coli O157:H7 (EDL933) and E. Coli K-12 (MG1655) in the mouse intestine. Infect. Immun. 72:1666-76
76. Momose Y, Hirayama K, Itoh K. 2008. Competition for proline between indigenous Escherichia coli and E. Coli O157:H7 in gnotobiotic mice associated with infant intestinal microbiota and its contribution to the colonization resistance against E. Coli O157:H7. Antonie van Leeuwenhoek 94:165-71
77. Moreau MC, Ducluzeau R, Guy-Grand D, Muller MC. 1978. Increase in the population of duodenal immunoglobulin A plasmocytes in axenic mice associated with different living or dead bacterial strains of intestinal origin. Infect. Immun. 21:532-39
78. Mundy R, Girard F, FitzGerald AJ, Frankel G. 2006. Comparison of colonization dynamics and pathology of mice infected with enteropathogenic Escherichia coli, enterohaemorrhagic E. Coli and Citrobacter rodentium. FEMS Microbiol. Lett. 265:126-32
79. Mundy R, MacDonald TT, Dougan G, Frankel G, Wiles S. 2005. Citrobacter rodentium of mice and man. Cell. Microbiol. 7:1697-706
80. Nakanishi N, Tashiro K, Kuhara S, Hayashi T, Sugimoto N, Tobe T. 2009. Regulation of virulence by butyrate sensing in enterohaemorrhagic Escherichia coli. Microbiology 155:521-30
81. Nardi RM, Silva ME, Vieira EC, Bambirra EA, Nicoli JR. 1989. Intragastric infection of germfree and conventional mice with Salmonella typhimurium. Braz. J. Med. Biol. Res. 22:1389-92
82. Ng KM, Ferreyra JA, Higginbottom SK, Lynch JB, Kashyap PC, et al. 2013. Microbiota-liberated host sugars facilitate post-Antibiotic expansion of enteric pathogens. Nature 502:96-99
83. Niess JH, Leithauser F, Adler G, Reimann J. 2008. Commensal gut flora drives the expansion of proinflammatory CD4 T cells in the colonic lamina propria under normal and inflammatory conditions. J. Immunol. 180:559-68
84. Nusrat A, von Eichel-Streiber C, Turner JR, Verkade P, Madara JL, Parkos CA. 2001. Clostridium difficile toxins disrupt epithelial barrier function by altering membrane microdomain localization of tight junction proteins. Infect. Immun. 69:1329-36
85. Ochoa-Reparaz J, Mielcarz DW, Wang Y, Begum-Haque S, Dasgupta S, et al. 2010. A polysaccharide from the human commensal Bacteroides fragilis protects against CNS demyelinating disease. Mucosal Immunol. 3:487-95
86. Pacheco AR, Curtis MM, Ritchie JM, Munera D, Waldor MK, et al. 2012. Fucose sensing regulates bacterial intestinal colonization. Nature 492:113-17
87. Palmer C, Bik EM, DiGiulio DB, Relman DA, Brown PO. 2007. Development of the human infant intestinal microbiota. PLOS Biol. 5:e177
88. Pothoulakis C, LaMont JT. 1993. Clostridium difficile colitis and diarrhea. Gastroenterol. Clin. N. Am. 22:623-37
89. Rea MC, Sit CS, Clayton E, O'Connor PM, Whittal RM, et al. 2010. Thuricin CD, a posttranslationally modified bacteriocin with a narrow spectrum of activity against Clostridium difficile. Proc. Natl. Acad. Sci. USA 107:9352-57
90. Rescigno M. 2011. The intestinal epithelial barrier in the control of homeostasis and immunity. Trends Immunol. 32:256-64
91. Rimoldi M, Chieppa M, Larghi P, Vulcano M, Allavena P, Rescigno M. 2005. Monocyte-derived dendritic cells activated by bacteria or by bacteria-stimulated epithelial cells are functionally different. Blood 106:2818-26
92. Round JL, Mazmanian SK. 2009. The gut microbiota shapes intestinal immune responses during health and disease. Nat. Rev. Immunol. 9:313-23
93. Russell SL, Finlay BB. 2012. The impact of gut microbes in allergic diseases. Curr. Opin. Gastroenterol. 28:563-69
94. Russell SL, Gold MJ, Hartmann M, Willing BP, Thorson L, et al. 2012. Early life antibiotic-driven changes in microbiota enhance susceptibility to allergic asthma. EMBO Rep. 13:440-47
95. Schmidt MA. 2010. LEEways: tales of EPEC, ATEC and EHEC. Cell. Microbiol. 12:1544-52
96. Sears P, Ichikawa Y, Ruiz N, Gorbach S. 2013. Advances in the treatment of Clostridium difficile with fidaxomicin: a narrow spectrum antibiotic. Ann. N. Y. Acad. Sci. 1291:33-41
97. Sekirov I, Finlay BB. 2009. The role of the intestinal microbiota in enteric infection. J. Physiol. 587:4159-67
98. Sekirov I, Gill N, Jogova M, Tam N, Robertson M, et al. 2010. Salmonella SPI-1-mediated neutrophil recruitment during enteric colitis is associated with reduction and alteration in intestinal microbiota. Gut Microbes 1:30-41
99. Sekirov I, Tam NM, Jogova M, Robertson ML, Li Y, et al. 2008. Antibiotic-induced perturbations of the intestinal microbiota alter host susceptibility to enteric infection. Infect. Immun. 76:4726-36
100. Smith K, McCoy KD, Macpherson AJ. 2007. Use of axenic animals in studying the adaptation of mammals to their commensal intestinal microbiota. Semin. Immunol. 19:59-69
101. Sorg JA, Sonenshein AL. 2008. Bile salts and glycine as cogerminants for Clostridium difficile spores. J. Bacteriol. 190:2505-12
102. Sorg JA, Sonenshein AL. 2009. Chenodeoxycholate is an inhibitor of Clostridium difficile spore germination. J. Bacteriol. 191:1115-17
103. Sprinz H, Kundel DW, Dammin GJ, Horowitz RE, Schneider H, Formal SB. 1961. The response of the germfree guinea pig to oral bacterial challenge with Escherichia coli and Shigella flexneri. Am. J. Pathol. 39:681-95
104. Stecher B, Chaffron S, Kappeli R, Hapfelmeier S, Freedrich S, et al. 2010. Like will to like: abundances of closely related species can predict susceptibility to intestinal colonization by pathogenic and commensal bacteria. PLOS Pathog. 6:e1000711
105. Stecher B, Robbiani R, Walker AW, Westendorf AM, Barthel M, et al. 2007. Salmonella enterica serovar Typhimurium exploits inflammation to compete with the intestinal microbiota. PLOS Biol. 5:2177-89
106. Stelter C, Kappeli R, Konig C, Krah A, Hardt WD, et al. 2011. Salmonella-induced mucosal lectin RegIIIβkills competing gut microbiota. PLOS ONE 6:e20749
107. Strauch UG, Obermeier F, Grunwald N, Gurster S, Dunger N, et al. 2005. Influence of intestinal bacteria on induction of regulatory T cells: lessons from a transfer model of colitis. Gut 54:1546-52
108. Theriot CM, Koenigsknecht MJ, Carlson PE Jr, Hatton GE, Nelson AM, et al. 2014. Antibiotic-induced shifts in the mouse gut microbiome and metabolome increase susceptibility to Clostridium difficile infection. Nat. Commun. 5:3114
109. Thiennimitr P, Winter SE, Winter MG, Xavier MN, Tolstikov V, et al. 2011. Intestinal inflammation allows Salmonella to use ethanolamine to compete with the microbiota. Proc. Natl. Acad. Sci. USA 108:17480-85
110. Turnbaugh PJ, Hamady M, Yatsunenko T, Cantarel BL, Duncan A, et al. 2009. A core gut microbiome in obese and lean twins. Nature 457:480-84
111. Uematsu S, Fujimoto K, Jang MH, Yang BG, Jung YJ, et al. 2008. Regulation of humoral and cellular gut immunity by lamina propria dendritic cells expressing Toll-like receptor.Nat. Immunol. 9:769-76
112. Umesaki Y, Okada Y, Matsumoto S, Imaoka A, Setoyama H. 1995. Segmented filamentous bacteria are indigenous intestinal bacteria that activate intraepithelial lymphocytes and induceMhc class IImolecules and fucosyl asialo Gm1 glycolipids on the small intestinal epithelial cells in the ex-germ-free mouse. Microbiol. Immunol. 39:555-62
113. Vallance BA, Deng W, Jacobson K, Finlay BB. 2003. Host susceptibility to the attaching and effacing bacterial pathogen Citrobacter rodentium. Infect. Immun. 71:3443-53
114. van der Waaij D, Berghuis-de Vries JM, Lekkerkerk-van der Wees JEC. 1971. Colonization resistance of the digestive tract in conventional and antibiotic-treated mice. J. Hyg. 69:405-11
115. Vazquez-Torres A, Jones-Carson J, Baumler AJ, Falkow S, Valdivia R, et al. 1999. Extraintestinal dissemination of Salmonella by CD18-expressing phagocytes. Nature 401:804-8
116. Vincent C, Stephens DA, Loo VG, Edens TJ, Behr MA, et al. 2013. Reductions in intestinalClostridiales precede the development of nosocomial Clostridium difficile infection. Microbiome 1:18
117. Voth DE, Ballard JD. 2005. Clostridium difficile toxins: mechanism of action and role in disease. Clin. Microbiol. Rev. 18:247-63
118. Wen L, Ley RE, Volchkov PY, Stranges PB, Avanesyan L, et al. 2008. Innate immunity and intestinal microbiota in the development of type 1 diabetes. Nature 455:U1109-10
119. Whitman WB, Coleman DC, Wiebe WJ. 1998. Prokaryotes: the unseen majority. Proc. Natl. Acad. Sci. USA 95:6578-83
120. Willing BP, Dicksved J, Halfvarson J, Andersson AF, Lucio M, et al. 2010. A pyrosequencing study in twins shows that gastrointestinal microbial profiles vary with inflammatory bowel disease phenotypes. Gastroenterology 139:1844-54e1
121. Willing BP, Vacharaksa A, Croxen M, Thanachayanont T, Finlay BB. 2011. Altering host resistance to infections through microbial transplantation. PLOS ONE 6:e26988
122. Willing BP, Van Kessel AG. 2007. Enterocyte proliferation and apoptosis in the caudal small intestine is influenced by the composition of colonizing commensal bacteria in the neonatal gnotobiotic pig. J. Anim. Sci. 85:3256-66
123. Wilson KH. 1993. The microecology of Clostridium difficile. Clin. Infect. Dis. 16(Suppl. 4):S214-18
124. Winter SE, Thiennimitr P, Winter MG, Butler BP, Huseby DL, et al. 2010. Gut inflammation provides a respiratory electron acceptor for Salmonella. Nature 467:426-29
125. Wlodarska M, Willing B, Keeney KM, Menendez A, Bergstrom KS, et al. 2011. Antibiotic treatment alters the colonic mucus layer and predisposes the host to exacerbated Citrobacter rodentium-induced colitis. Infect. Immun. 79:1536-45
126. Wu HJ, Ivanov II, Darce J, Hattori K, Shima T, et al. 2010. Gut-residing segmented filamentous bacteria drive autoimmune arthritis via T helper 17 cells. Immunity 32:815-27
127. Zachar Z, Savage DC. 1979. Microbial interference and colonization of the murine gastrointestinal tract by Listeria monocytogenes. Infect. Immun. 23:168-74
128. Zaph C, Du Y, Saenz SA, Nair MG, Perrigoue JG, et al. 2008. Commensal-dependent expression of IL-25 regulates the IL-23-IL-17 axis in the intestine. J. Exp. Med. 205:2191-98
129. Zhang H, DiBaise JK, Zuccolo A, Kudrna D, Braidotti M, et al. 2009. Human gut microbiota in obesity and after gastric bypass. Proc. Natl. Acad. Sci. USA 106:2365-70